ArticleVaccines2022

Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.

Nicola Cotugno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.